Globus Medical (GMED) Change in Account Payables (2011 - 2026)
Globus Medical (GMED) posted Change in Account Payables of $5.1 million for Q1 2026, down 44.4% on a QoQ basis from $9.1 million in Q4 2025, and up 665.29% year-over-year from $664057.8 in Q1 2025.
Globus Medical (GMED) Change in Account Payables (2011 - 2026) Analysis & Trends
Globus Medical's Change in Account Payables history runs 16 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- Quarterly Change in Account Payables rose 665.29% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.5 million (down 35.75% YoY) and the FY2025 annual result came in at $8.5 million, down 51.95% from the prior year.
- Change in Account Payables was $5.1 million for Q1 2026 at Globus Medical, down from $9.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $17.3 million in Q2 2024 and bottomed at -$10.3 million in Q3 2024.
- A 5-year average of $1.8 million and a median of $3.4 million in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables sank 811.11% — and 2026, when it jumped 665.29%.
- Globus Medical's Change in Account Payables stood at $4.0 million in 2022, then sank by 256.35% to -$6.3 million in 2023, then soared by 361.03% to $16.4 million in 2024, then slumped by 44.16% to $9.1 million in 2025, then tumbled by 44.4% to $5.1 million in 2026.
- Business Quant data shows GMED's Change in Account Payables at $5.1 million in Q1 2026, $9.1 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 9.14 Mn |
| Dec 31, 2025 | 9.14 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | -3.19 Mn |
| Jun 30, 2025 | -3.19 Mn |
| Mar 31, 2025 | -899,000.00 |
| Mar 31, 2025 | -899,000.00 |
| Dec 31, 2024 | 16.37 Mn |
| Dec 31, 2024 | 16.37 Mn |
| Sep 30, 2024 | -10.27 Mn |
| Sep 30, 2024 | -10.27 Mn |
| Jun 30, 2024 | 17.31 Mn |
| Jun 30, 2024 | 17.31 Mn |
| Mar 31, 2024 | -5.75 Mn |
| Mar 31, 2024 | -5.75 Mn |
| Dec 31, 2023 | -6.27 Mn |
| Dec 31, 2023 | -6.27 Mn |